Article
The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2- breast cancer patients
2026-03-26
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> The tumour microenvironment (TME) influences breast cancer progression and treatment response. We investigated whether TME composition predicts tamoxifen benefit in postmenopausal women with oestrogen receptor-positive, HER2-negative (ER+HER2-) breast cancer. <h4>Methods</h4> This study included 513 patients from the Stockholm Tamoxifen (STO-3) trial, which randomised postm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d801e947-b6af-57d7-a35e-e1dce1e57017
- DOI
- 10.64898/2026.03.24.26349151
